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Abstract 
Poly(ester amide)s have emerged in the last years as an important family of biodegradable 
synthetic polymers. These polymers present both ester and amide linkages in their structure and 
they gather in the same entity the good degradability of polyesters with the good thermo-
mechanical properties of polyamides. Particularly, poly(ester amide)s containing α-amino acids 
have risen as important materials in the biomedical field. The presence of the α-amino acid 
contributes to better cell-polymer interactions, allows the introduction of pendant reactive groups, 
and enhances the overall biodegradability of the polymers. 
This review summarizes the recent advances in the development of α-amino acid based poly(ester 
amide)s, the main synthetic pathways used in their preparation along with their  main biomedical 
applications. 
 
Keywords: Poly(ester amide)s, polydepsipeptides, synthesis strategies, biomedical applications 
 
Abbreviations 
BAAD bis-α-(L-amino acid)-α,ω-alkylene diesters 
ε-CL ε-caprolactone 
α-CT α-chymotrypsin 
DDS drug delivery system 
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DMA N,N’-dimethylacetamide 
DMF N,N’-dimethylformamide 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
Et3N triethylamine 
GA glycolic acid 
GDS gene delivery system 
HCASMCs human coronary artery smooth muscle cells 
LA lactic acid 
L-LA L-lactic acid 
MTT 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphofenyl)-2H-
tetrazolium inner salt 
PBS phosphate buffered saline 
PCL poly(ε-caprolactone) 
PDLA poly(D -lactic acid) 
PDLLA poly(D,L-lactic acid) 
PDP polydepsipeptide 
pDNA plasmid DNA 
PEA poly(ester amide) 
PEG-DA poly(ethylene glycol) diacrylate  
PEI poly(ethyleneimine) 
PEO poly(ethylene oxide) 
PGA poly(glycolic acid) 
PLA poly(lactic acid) 
PLGA poly(lactic-co-glycolic acid) 
PLLA poly(L-lactic acid) 
PLHP poly(D,L-lactide-co-hydroxy-L-proline) 
PLys poly(L-lysine) hydrochloride 
p-TSA p-toluene sulfonic acid 
RNA ribonucleic acid 
ROP ring opening polymerization 
TEMPO 2,2,6,6-tetramethylpiperidine oxide 
TMED N,N,N’,N’- tetramethylethylenediamine 
UPEA unsaturated poly(ester amide)s 
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1 Introduction 
 
Biodegradable synthetic polymers are a class of materials with an importance in the biomedical 
field well recognized since the early 1960s.  The great advantage of these polymers relies on the 
fact that their removal by surgical procedures after use is not necessary, because they degrade with 
time, giving products that are metabolized or excreted from the organism via natural pathways. In 
addition, biodegradable synthetic polymers can overcome problems related to the long-term 
presence of a foreign material in the human body.  This class of polymers may be prepared with a 
variety of compositions and adjustable properties to match a specific application [1-3].  
Biodegradable polymers may be degraded by the cleavage of linkages in their backbone, both by 
non-enzymatic hydrolysis and by enzyme-catalyzed hydrolysis. Non-enzymatic hydrolysis involves 
the breakage of the linkages in polymer backbone by the attack of water to form oligomers and 
ultimately monomers. This type of degradation occurs in polymers with a structure presenting 
specific chemical groups, such as: anhydride, orthoester, ester, amide or urea [4]. In turn, enzyme-
catalyzed hydrolysis degradation occurs in natural polymers and synthetic polymers prepared from 
natural occurring monomers (e.g., glycolic acid (GA), D,L-lactic acid (DLLA), amino acids) or 
analogs of natural occurring monomers (e.g., dimethylglycolic acid, ε-caprolactone (ε-CL), p-
dioxanone) [4]. Proteases, estereases, glycosidases, and phosphatases are examples of enzymes 
typically involved in the biodegradation process [5]. When the biodegradation of polymers is 
concerned, several aspects have to be taken into consideration. Among them are the molecular 
weight, crystallinity, hydrophilicity and pH of the surrounding medium [4, 6].  
The use of biodegradable materials in biomedical applications is not a trivial issue. Indeed, a 
material that is intented to be used in biomedical field should present a set of properties  that make 
it suitable to be introduced in the human body. Such properties are listed below [2, 3, 7]: 
- the material should not cause an inflammatory or toxic response upon implantation in the 
body; 
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- the degradation time of the material should match the healing or regeneration process; 
- the mechanical properties of the polymer should be appropriate for the intended application 
and the changes in mechanical properties with degradation should be compatible with the 
healing or regeneration process; 
- the degradation products should be non-toxic, and able to be metabolized and cleared from 
the body; 
- the permeability and processability of the material should be suitable for the intended 
application; 
- the material should be easily sterilized; 
- the material should have acceptable shelf-life. 
Hence, the crucial properties depend on both the final application and the ultimate degradation 
products of the materials.  The main challenges faced by researchers around the world  deal with 
the preparation of suitable polymers for diverse biomedical applications and, at the same time, with 
safe degradation products.  Motivated by addressing such issues scientists of diverse areas (e.g., 
chemistry, engineering, biology, medicine, pharmaceutics) come together and created 
multidisciplinary research teams as a route to find optimal and integrated solutions [3].   
The safety of the products that result from the degradation of biodegradable polymers is a major 
concern, leading to interest in the design of polymeric materials with building blocks that are 
natural metabolites in the human body. Among such materials are poly(α-hydroxy acid)s, 
poly(amino acid)s and  poly(ester amide)s (PEAs) based on amino acids and/or α-hydroxy acids [8, 
9].  
Poly(α-hydroxy acid)s are biodegradable and biocompatible polymers widely used in diverse 
biomedical areas. The most used poly(α-hydroxy acid)s in biomedical applications are 
poly(glycolic acid) (PGA), poly(lactic acid) (PLA), and their copolymer, poly(lactic-co-glycolic 
acid) (PLGA) (Figure 1) [10-13] . 
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<Insert Figure 1> 
PGA is the simplest linear aliphatic polyester, being synthesized either by the ring opening 
polymerization (ROP) of glycolide or by the polycondensation of glycolic acid (GA). It is a semi-
crystalline polymer, with high melting point (Tm = 221-231 ºC) and presents low solubility in most 
common organic solvents.  It has also high strength modulus and stiffness. Sutures totally made 
from PGA have been available on the market since 1970 under the trade name of DEXON®. PGA 
has also been used in the design of internal bone fixation devices, commercially available under the 
trade name BIOFIX® [7, 10].  
PLA can be obtained either from the polycondensation of lactic acid (LA) or from the ROP of 
lactide [14, 15]. It exists in four different morphological forms: poly(L-lactic acid) (PLLA), 
poly(D-lactic acid) (PDLA), the racemic poly(D,L-lactic acid) (PDLLA) and meso-PLA. The 
optically active PLLA and PDLA are semi-crystaline polymers, whereas the PDLLA is amorphous 
[3, 10].  In the biomedical field, only PLLA and PDLLA have shown promising results and have 
been extensively studied. PLLA has a glass transition temperature Tg between 60-65 ºC and a 
melting temperature Tm of about 175 ºC. It has good tensile strength and a low elongation and high 
modulus, which makes it a good candidate for load bearing applications (e.g., orthopedic fixation 
devices) [2, 3, 16]. In turn, PDLLA with a Tg of 55-60 ºC, presents lower tensile strength and 
higher elongation, but faster degradation times when compared to PLLA, which makes it more 
attractive for drug delivery purposes [7]. 
The copolymerization of GA and LA is a very elegant way to gather the advantages of the 
homopolymers and, at the same time, overcome some of their limitations.  The physical properties 
and the biodegradability of PLGA can be tuned by changing the ratio between GA and LA during 
polymerization. PLGA finds application in drug delivery systems (DDS) and tissue engineering 
applications [3, 11]. 
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PLA, PGA and PLGA can be degraded through non-enzymatic or enzymatic hydrolysis of the ester 
bond, giving as degradation products natural metabolites in the human body (LA and GA) [2, 3]. 
Since those polyesters are considered safe and biocompatible by regulatory agencies, they have 
been investigated more than any other degradable polymer in the biomedical field [10].   
Poly(amino acid)s appear to be a logical and promising choice for biomedical applications by 
virtue of their structural similarity with proteins. The toxicity of such polymers is expected to be 
very low since upon degradation they release amino acids [10, 17]. In addition, the pendant groups 
in the amino acids can be further functionalized or can be used to attach drugs [10, 18].  Despite the 
recognized advantages, poly(amino acid)s have found a reduced number of applications, due to 
their high crystallinity, low degradation rate, unfavorable mechanical properties and antigenicity [2, 
3]. Until now, only poly(L-glutamic acid) and poly(aspartic acid) (Figure 2) have found practical 
applications (e.g., DDS) in biomedical field [3].  
<Insert Figure 2> 
Nevertheless, the use of α-amino acids in the synthesis of polymers is an attractive way to obtain 
materials with good biological properties, including cell-materials interactions and enzymatic 
biodegradation, and whose building blocks are metabolizable [17, 18]. In fact, α-amino acids have 
been explored in the preparation of polyamides,       poly(amide-imide)s, poly(ester imide)s and 
PEAs for application in biomedical/pharmaceutical field [17, 18]. α-Amino acids based PEAs have 
attracted considerable attention from the scientific community because they can present all the 
advantages associated with the presence of the α-amino acids, as well as the good properties of 
PEAs (vide infra). Indeed, it is possible to find several reports in literature dealing with their 
synthesis, characterization and biological properties [17, 19, 20]. Also in the family of PEAs, block 
copolymers of α-hydroxy acids with α-amino acids, commonly known as polydepsipeptides 
(PDPs), emerged as important biodegradable biomaterials [9, 21]. The properties of such families 
of PEAs and the synthesis methods available for their preparation will be discussed in detail below.  
Page 8 of 50
Ac
ce
pte
d M
an
us
cri
pt
8 
 
 
2 Poly(ester amide)s: promising materials for biomedical applications 
 
PEAs can be generically defined as polymers with ester and amide linkages in their polymeric 
chain, with properties between those of polyesters and polyamides [20, 22]. Polyesters degrade 
under physiological conditions through the cleavage of the ester linkages, have better solubility in 
many organic solvents, and have better flexibility than polyamides. In turn, polyamides are known 
to have superior thermal and mechanical properties due to the formation of strong hydrogen bonds 
between the amide linkages of individual chains [20]. However, a long time may be required for 
polyamides to degrade in the human body. Because of that, they are often considered to be 
(effectively) non-degradable materials. Thus, the combination of ester and amide linkages in the 
same polymer can open avenues in the design of new materials with different properties (e.g., 
thermomechanical and degradability) for use in biomedical applications [22, 23].  
Different monomers (e.g., α-amino acids, α-hydroxy acids, cyclic depsipeptides, fatty diacids, 
diols, α,ω-aminoalcohols, carbohydrates) have been used in the synthesis of PEAs to afford 
polymers with different properties [20, 23, 24].  The focus of this literature review will be PEAs 
based on α-amino acids, fatty diacids and diols and PDPs. 
 
2.1 Poly(ester amide)s based on α-amino acids, fatty dicarboxylic acids and diols 
 
The PEAs based on α-amino acids combine the interesting properties of conventional PEAs with 
those resulting from the presence of the α-amino acid (e.g., enzymatic degradability, improvement 
of cell-materials interactions, introduction of functional groups for the attachment of drugs or 
peptides) [18]. The methods currently available for the synthesis of such PEAs are melt 
polycondensation, interfacial polymerization, and active solution polycondensation [20, 23]. 
 
2.1.1 Synthesis of PEAs by melt polycondensation 
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The melt polycondensation involves the reaction of a diol with a diamide-diester, previously 
obtained from the condensation of a diacyl chloride with a α-amino acid methyl ester [20, 23]. 
The melt polycondensation usually proceeds in two steps. The first step occurs at low temperatures 
(ca. 0 ºC), in the presence of a base, usually triethylamine (Et3N), under a nitrogen atmosphere to 
yield the diamide-diester. The triethylamine hydrochloride that is formed during this reaction step 
is removed by extraction with water.  In the second step, a pre-polymer is  obtained by heating the 
purified diamide-diester at temperatures between 160 ºC and 190 ºC, under nitrogen, at atmospheric 
pressure. The temperature is then increased to 200-220 ºC, and vacuum is applied to favor the 
condensation process and increase the molecular weight of the polymer (Scheme 1) [25, 26]. 
<Insert Scheme 1> 
From an industrial standpoint, this method is advantageous since no post-treatment of the polymer 
is necessary. However, the need to purify the diamide-diester in the first step of the reaction, and 
the high reaction temperatures employed, that can lead to undesirable side reactions (e.g., 
racemization), can both be seen as important disadvantages of this method [20, 23]. 
Asín et al. [25] prepared PEAs by melt polycondensation from glycine, different diols and 
dicarboxylic acids. The yields of reaction were between 80 and 90%, the only exception being the 
reaction in which ethylene glycol was used. The PEAs were obtained with intrinsic viscosities ([η]) 
between 0.35 and 0.70 dL g-1 (dichloroacetic acid, 25 ºC); those with [η] > 0.5 dL g−1 could form 
both films and fibers. The Tg was determined by DSC and the values obtained ranged from 17 to 87 
ºC, being the highest values obtained for the PEAs containing aromatic units in the structure.  The 
presence of glycine in the PEAs’ structure allowed their degradation by papain, a proteolytic 
enzyme.  The work of Montané et al. [26] also exploited the use of thermal polycondensation for 
the synthesis PEAs. The monomers used were 1,4-butanediol, sebacic acid, and the α-amino acids 
glycine and L-alanine. The PEAs based on glycine and L-alanine presented [η] values 
(dichloroacetic acid, 25 ºC) of 0.73 and 0.80 dL g−1, respectively and both showed the ability to 
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form films or fibers. The thermal analysis indicated that the lateral group of L-alanine decreased 
the cristallinity of the PEAs, with a concomitant decrease in the Tm value.  The tests carried out to 
evaluate the biodegradation behavior showed that the L-alanine based PEA shows a higher value of 
weight loss when compared to glycine based PEA. In the presence of papain and proteinase K, the 
L-alanine based PEA degrades completely.   However, the degradation tests carried out on the same 
PEA under simulated physiological conditions (PBS pH=7.4, 37 ºC) showed a weight loss of about 
7.5% after 150 days. 
 
2.1.2 Synthesis of PEAs by solution polycondensation 
Solution polycondensation has been developed to address the main issues related to the melt 
polycondensation reactions, namely the undesirable side reactions resulting from the higher 
temperatures used. Solution polycondensation is characterized by mild reaction conditions (T < 80 
ºC and atmospheric pressure), high polymerization rates, and minimal side reactions. Usually, the 
polymers obtained by solution polycondensation present high molecular weights [20].  
This method promotes the reaction of dicarboxylic acids with diamines either by the use of 
condensing agents or by the activation of carboxylic acid groups [20]. The activation of carboxylic 
groups is a well known method in peptide chemistry, consists in the reactions of carboxylic groups 
with the so-called leaving groups or condensing agents (Figure 3), leading to the formation of 
amides or esters [27]. Because of that, solution polycondensation is often called active solution 
polycondensation. 
<Insert Figure 3> 
The synthesis of α-amino acids based PEAs by active solution polycondensation was proposed by 
Katasarava et al. during the 1980s and continues to be one of the most used methods [18, 27, 28]. 
The carboxylic acid is activated with the leaving group (X), yielding activated esters [29], which 
subsequently react with the amino groups, releasing HX as by-product (Scheme 2). 
<Insert Scheme 2> 
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The synthetic route for the preparation of α-amino acid based PEAs through active solution 
polycondensation comprises three main steps (Scheme 3) [28]: 
1) Preparation of the activated ester either from dicarboxylic acids or diacyl chlorides, in the 
presence of  a condensing agent (e.g., dicyclohexylcarbodiimide, DCC) or a tertiary amine 
(e.g., Et3N) , respectively. Nitrophenyl esters (1) are the most widely used activated 
diesters in solution polycondensation; 
2) Preparation of bis-α-(L-amino acid)-α,ω-alkylene diesters (BAAD) from α-amino acids and 
different diols. These compounds have two ester linkages structure that can undergo either 
specific (enzymatic) or non-specific (chemical) hydrolysis.  The BAAD are prepared as 
salts (2) since they are unstable and can participate in undesirable side reactions as free 
bases.  The most used method for their preparation is the Fischer esterification between 
diols and α-amino acids, in the presence of p-toluenesulfonic acid monohydrate (pTSA). 
pTSA serves as both catalyst and amino group protector, preventing undesirable side 
reactions including the amine interaction with the ester groups of the di-p-toluenesulfonic 
acid salts of BAAD [30]. This method was proposed for the first time by Huang et al. [31] 
in 1979 and although with some modifications, it remains the method used in the 
preparation of such monomers. It allows the preparation of BAAD from a variety of diols 
(e.g., diols derived from renewable resources [32, 33], oligoethylene glycols [34], poly(ε-
caprolactone)diol [35] and α-aminoacids (or α-amino acid derivatives), including those 
containing pendant groups (e.g., L-lysine [36], L-arginine [37, 38], allylglycine [39] , 
serine [40]). 
3) Solution polycondensation of  (1) and (2) under mild conditions (T ≈ 60 ºC), in common 
organic solvents (e.g., chloroform (CHCl3), N,N’-dimethylformamide (DMF), N,N’-
dimethylacetamide (DMA)) in the presence of a tertiary amine (e.g., Et3N, N-
methylmorpholine, N,N,N’,N -tetramethylethylenediamine (TMED)) [28]. Usually, 
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the PEAs obtained by solution polycondensation present high molecular weight (24,000 < 
Mw< 167,000) and low polydispersity index (1.20 < PDI < 1.81).   
<Insert Scheme 3> 
Table 1 gives an overview of the different monomers and conditions in the preparation of several 
α-amino acid PEAs by solution polycondensation. 
<Insert Table 1> 
Solution polycondensation is an attractive method for the preparation of PEAs, but it has some 
important drawbacks that have to be taken into consideration.  It requires monomers with a high 
purity degree to allow the correct stoichiometric balance and by that means afford polymers with 
high molecular weight [19]. In addition, after reaction, it is necessary to purify the polymer very 
carefully to remove the solvent and generated by-products (e.g., p-nitrophenol) that are known to 
be toxic [18]. 
 
2.1.3 Synthesis of PEAs by interfacial polycondensation 
Interfacial polymerization is a fast and irreversible polycondensation that occurs at the interface of 
two immiscible phases, usually water/organic solvent, each containing a difunctional reactant. It is 
based on the Schotten-Baumann reaction in which a diacyl chloride is made to react with 
compounds containing active hydrogen atoms (-OH, -NH and -SH).  The interfacial polymerization 
occurs at temperatures between ca. 0 and     50 ºC and does not require overall bulk stoichiometry 
of the reactants in the two phases, since it promptly occurs at the interface where polymerization 
proceeds. There is always a supply of both reactants at the interface due to diffusion of the 
reactants from the immiscible phases [49, 50]. The success of the polymerization reaction depends 
on several parameters. The presence of an inorganic base is necessary in the aqueous phase to 
neutralize the hydrogen chloride formed during the reaction, or otherwise the diamine will be 
converted in its unreactive amine hydrochloride salt, lowering the reaction rates. Also, hydrolysis 
of the diacyl chloride to the respective diacid must be avoided since the diacid  is unreactive under 
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the interfacial polymerization conditions, resulting in a lower polymerization rate and limiting the 
polymer molecular weight [49-51].  The use of diacyl chlorides of long aliphatic or aromatic chains 
will prevent hydrolysis, due to their low affinity to the aqueous medium. The organic solvent must 
be carefully selected, so that the polymer will precipitate only when it attains a molecular weight 
adequate for the intended application [49-51].  
Taking advantage of the interesting characteristics of interfacial polymerization, many research 
groups have used the method to synthesize α-amino acid based PEAs. The overall synthetic route is 
very simple and can be divided in two steps (Scheme 4): 
1) Preparation of the di-p-toluenesulfonic acid salts of BAAD by the Fischer esterification 
between α-amino acids and diols, in the presence of p-TSA [31];  
2) Reaction of the di-p-toluenesulfonic acid salts of BAAD with diacyl chlorides, in the 
presence of a proton acceptor [52]. 
Table 2 presents the diverse α-amino acid based PEAs synthesized by interfacial polymerization. 
<Insert Scheme 4> 
 
<Insert Table 2> 
Both active solution polycondensation and interfacial polymerization are remarkably versatile 
methods for the preparation of a wide range of PEAs by varying one of the three building 
monomers (α-amino acid, diol, diacyl chloride). Active solution polycondensation is undoubtedly 
the most used method. However, recently the attention has been moved towards interfacial 
polymerization due to its simple and fast nature [47, 59, 60]. 
 
2.2 Poly(ester amide)s based on α-amino acids and α-hydroxy acids- Polydepspipeptides 
 
PDPs are alternating copolymers of α-hydroxy acids and α-amino acids constituting an interesting 
family of biodegradable PEAs. PDPs are known to be non-toxic, since upon degradation they 
Page 14 of 50
Ac
ce
pte
d M
an
us
cri
pt
14 
 
release α-amino acids and α-hydroxy acids, which are metabolites recognized by the human body. 
Since both acidic and basice  degradation products result, neutralization occurs, preventing an 
accentuated pH decrease, a phenomenon otherwise commonly observed in polyesters degradation 
[9, 21]. The preparation of PDPs was firstly carried out by the polycondensation of depsipeptide 
monomeric units using methods employed in peptide synthesis. This strategy is inefficient, 
involving several protection/deprotection steps, making the implementation at large scale 
impracticable [8, 21]. PDPs are mainly prepared by the ROP of cyclic depsipetides, or by the melt 
polycondensation of α-hydroxy acids with α-amino acids [9, 18]. The use of interfacial 
polycondensation [61] and solution polycondensation [62] in the preparation of PDPs has also been 
reported.  
 
2.2.1 ROP of Depsipeptides 
In order to overcome the limitations presented by the polycondensation of depsipeptide monomeric 
units, in 1985, Helder et al. [63] proposed the synthesis of PDPs by the ROP of morpholine-2,5-
dione derivatives (Scheme 5). 
<Insert Scheme 5> 
The ROP of morpholine-2,5-dione derivatives is usually carried out in bulk, in most cases using 
stannous octanoate (Sn(Oct)2) as catalyst, with an efficiency demonstrated in the ROP of cyclic 
diesters and lactones [9, 20, 21].  Enzymes can also be used, but in the enzyme catalyzed-ROP, the 
reaction behavior is strongly affected by the configurations of the LA residues in the monomer, 
since the ROP takes place at the ester group of the morpholine-2,5-dione derivatives [24].  
Morpholine-2,5-dione derivatives having R1 bulky substituents are less reactive than L-lactide, and 
their ROP yields polymers with low molecular weight (Mn < 20,000 g mol−1). Although this can be 
partly attributed to steric hindrance effects, other reasons can be ascribed to the lower reactivity, as 
demonstrated by Chisholm et al.  [64]. The authors suggested that the difference in reactivity is due 
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to: 1) possible coordination of the morpholine-2,5-diones to a metal complex in a non-productive 
manner via the more nucleophilic ketonic oxygen of the amide group; and 2) reaction of the N-H 
groups present in the cyclic monomer leading to stable chelating agents, that are kinetically inert to 
further ring-opening of the morpholine-2,5-dione derivative, if the ROP occurs by the attack of the 
ester group. Also, the cyclic monomers made from protected trifunctional α-amino acids have 
shown low reactivity towards ROP, mainly due to steric hindrance effects [18, 21]. 
Although being the most used method for the synthesis of PDPs, ROP presents some important 
disadvantages, including, [28] the severe reaction conditions used in the ROP that may cause 
undesirable side reactions (e.g., intra- and intermolecular transesterification), and the limited 
available synthetic routes for the synthesis of morpholine-2,5-diones and the low yields sometimes 
observed in their preparation, especially in the case of trifunctional α-amino acids (ca. 30 %), the 
formation of low molecular weight oligomers or polymers with low thermomechanical properties. 
The copolymerization of morpholine-2,5-dione derivatives  with other cyclic monomers  
(glycolide, lactide, ε-caprolactone (ε-CL)) (Scheme 6) is also possible and gives random coPDPs 
[8], with thermomechanical properties considerably better than those of the homoPDPs. In addition, 
changes in the copolymers properties can be easily achieved by the amounts of the monomers in 
the feed. 
<Insert Scheme 6> 
Helder et al. [65] reported the synthesis of random copolymers based on D,L-lactide  and 
depsipeptides comprising DL-LA and glycine, with molecular weights Mw increasing from 10,000 
to 235,000 g.mol-1 as the D,L-lactide content went from to 0 to 100 %.  
Regarding the copolymerization of morpholine-2,5-dione derivatives including pendant groups 
with cyclic monomers, the results obtained in the first attempts were not very encouraging. Only 20 
% of the depsipeptide unit was incorporated in the final polymer and during the deprotection step 
some degradation of the polymer was observed [66].  Nevertheless, due to the contribution of 
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several research groups, copolymers containing ca. 70 % of depsipeptide units were obtained, their 
properties tuned by the amount of morpholine-2,5-dione derivatives in the feed [67-72].  Table 3 
gives an overview of the different PDPs (homo and copolymers) synthesized over the years. 
<Insert Table 3> 
 
2.2.2 Melt Polycondensation of α-hydroxy acids with α-amino acids 
The preparation of PDPs by direct melt polycondensation has gained interest in the last few years, 
mainly because no cyclic depsipeptides are necessary for the reaction. The polymerization is 
carried out using α-hydroxy acids and α-amino acids [85]. The melt polycondensation is carried 
out at high temperatures and reduced pressure, in the presence of metallic catalysts (Scheme 7). It 
is seen as a very simple and straightforward method for the preparation of PDPs. 
<Insert Scheme 7> 
In 2003, Shinoda et al. [86] proposed the synthesis of poly(lactic-co-aspartic acid) by the melt 
polycondensation of L-aspartic acid and L-lactide, at 160 ºC, in the absence of catalysts and 
solvents. The polymer had molecular weights Mw between 6,000 and 24,000 g.mol−1. The method 
proposed is not only easy but also environmentally friendly. However, the use L-lactide instead of 
L-LA makes the method somewhat expensive [87]. Thus, in order to overcome the economic 
drawback, the investigation on the preparation of PDPs by melt polycondensation has been 
centered on the use of LA and GA instead of their cyclic counterparts [87-90].  Table 4 lists the 
different PDPs prepared from the direct polycondensation of α-hydroxy acids with α-amino acids. 
<Insert Table 4> 
 
This method is an attractive alternative to the ROP of cyclic depsipeptides for the preparation of 
PDPs. However, the occurrence of undesirable side reactions (e.g., racemization) due to the high 
reaction temperatures [20] and the use of metallic catalysts, that are known to be toxic [91], 
constitute important disadvantages. 
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2.2.3 Alternative methods for the synthesis of PEAs containing α-hydroxy acids and    α-amino 
acids 
ROP of cyclic depsipeptides and melt polycondensation of α-hydroxy acids and          α-amino 
acids are the most used methods in the preparation of PDPs.  However, in the last years two 
alternative synthetic routes have been proposed.  
In 2001, D’Angelo et al. [61] proposed the synthesis of segmented PEAs based on α-hydroxy acids 
and α-amino acids by interfacial polymerization.  The proposed synthetic route comprised three 
main steps:  
1) Preparation of diamines or amide-diamines based on α-amino acids;  
2) Preparation of diacyl chlorides from hydroxyl terminated L-LA oligomers; 
3) Interfacial polycondensation.   
As mentioned in section 2.1.3, interfacial polymerization is a very simple and fast polymerization 
method and its use in the synthesis of PDPs would be advantageous. However, in the D’Angelo et 
al. approach, the preparation of the diamine monomer to be used in the interfacial 
polycondensation is quite inefficient (e.g., several protection/deprotection steps using methods of 
peptide chemistry). This aspect can be considered the main drawback in this synthetic 
methodology. In addition, the hydroxyl terminated L-LA oligomers were prepared from the L-
lactide, an expensive monomer [87].  
Very recently, Katsarava et al. [62] proposed the synthesis of PDPs by solution polycondensation. 
In this method, the p-toluene sulfonic acid salts of BAAD were made to react with nitrophenyl 
esters derived from α-hydroxy acids.  The preparation of the α-hydroxy acid based nitrophenyl 
ester included two steps:  
1) Reaction of the α-hydroxy acid with a diacyl chloride, yielding a dicarboxylic acid; 
2) Reaction of the dicarboxylic acid with p-nitrophenol, in the presence of thionyl chloride and 
pyridine.  
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The overall synthetic route for obtaining polydepsipeptides by solution polycondensation is 
presented in Scheme 8. 
<Insert Scheme 8> 
The solution polycondensation is an attractive method for the preparation of α-amino acid / α-
hydroxy acid based PEAs. However, as already discussed, it is necessary to carefully purify the 
polymer after the reaction in order to remove the toxic by-products and solvents.   
The different synthetic routes presented here have advantages and disadvantages (Table 5), and 
none of the methods presented can be considered perfect.   
<Insert Table 5> 
This means that there is still a space for research to explore alternative synthetic routes for the 
preparation of PEAs based on α-amino acids and/or α-hydroxy acids. In this regard, our research 
group proposed an easy and straightforward method for the synthesis of such PEAs based on the 
interfacial polymerization between BAAD and L-LA based diacyl chlorides. The methods used in 
the preparation of the monomers were simple, involving inexpensive starting materials.  Different 
PEAs were obtained and their properties (e.g., thermal and biological) were easily tuned by 
changes in the    α-amino acid or in the α-hydroxy acid based diacyl chloride. The PEAs presented 
the ability to support the growth and proliferation of human dermal fibroblasts, showing a very low 
cytotoxicity, which is one of the main important characteristics for biomedical applications [92, 
93]. 
3 Biomedical applications of poly(ester amide)s based on α-amino acids and/or α-hydroxy 
acids 
The demand of new synthetic biodegradable and biocompatible polymers in biomedical field has 
increased significantly in the last decades. After having looked at the main properties of PEAs and 
the methods available for their preparation, it is now important to give an overview about their 
main biomedical applications. 
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3.1 Drug delivery systems (DDSs) 
DDS enhance drug targeting specificity, decrease systemic drug toxicity and provide the drug with 
protection against biochemical degradation [21]. In this field, biodegradable polymers, including 
PEAs based on α-amino acids and/or α-hydroxy, acids have been extensively investigated and 
successfully used [3]. The most representative examples of the use of PEAs based on α-amino 
acids, fatty dicarboxylic acids and diols on DDS are presented below.  
Guo and Chu [94] prepared hybrid hydrogels from unsaturated L-phenylalanine based PEAs 
(UPEA) and poly(ethylene glycol) diacrylate  (PEG-DA) loaded with paclitaxel. The drug-loaded 
hydrogels were obtained by the photopolymerization of formulations containing pre-determined 
amounts of UPEA, PEG-DA, photoinitiator and paclitaxel. The release of the drug was dependent 
on the UPEA/PEG-DA ratio, and when this ratio increased, the initial burst release of the drug was 
significantly reduced.  Hydrogels made from formulations containing 30 % (w/w) of UPEA 
showed a sustained and almost linear release over two months. The amount of paclitaxel released 
was about 35 %. When the hydrogels were placed in contact with α-CT containing aqueous 
medium, ca. 55 % of paclitaxel was released. The release of the drug in the enzymatic medium was 
faster than in the aqueous medium. The authors claimed that this system can be successfully used 
for the long-term and sustained release of hydrophobic drugs. Paclitaxel was also encapsulated in 
biodegradable L-phenylalanine based PEAs microspheres by the same researchers [95]. The 
microspheres, fabricated by an oil-in-water emulsion/ solvent evaporation technique, presented 
diameters below 1 μm and narrow particle size distributions. The biodegradation of the PEAs 
microspheres proceeded through a surface eroding mechanism, under the action of α-CT. Paclitaxel 
loaded microspheres with high encapsulation efficiency (ca. 95 %) were obtained without 
significantly affecting their size and morphology. Taking into account the overall results, the 
authors anticipated the use of such microspheres in the administration of hydrophobic anti-cancer 
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drugs. However, it should be mentioned, that in this work the authors did not present any study 
regarding the release behavior of paclitaxel from the microspheres. 
Li and Chu [96] prepared electrospun nanofibers, with an average diameter of 640 nm,  from a PEA 
based on L-phenylalanine, 1,4-butanediol and sebacic acid. The nanofibres were pre-loaded with 4-
amino-2,2,6,6-tetramethylpiperidine oxide (4-amino-TEMPO) and its release was studied under 
simulated physiological conditions (pH = 7.4 PBS, 37 ºC) and in PBS containing α-CT. About 38 
% of the loaded 4-amino-TEMPO was released in a sustained manner, during a 1 month incubation 
period (37 ºC in PBS pH = 7.4). In the enzymatic medium, the active compound was completely 
released from the nanofibers after 5 days of incubation. The authors suggested that the electrospun 
PEA nanofibers were interesting candidates as delivery vehicles for the localized administration of 
4-amino-TEMPO nitroxyl radical for certain therapeutic applications. 
del Valle et al. [55] prepared ibuprofen-loaded porous matrices from a PEA based on  L-alanine, 
sebacic acid and 1,12-dodecanodiol, by the compression-molding/ particulate leaching method.  
Epithelial-like cells derived from Madin-Darby canine kidney were able to proliferate and grow on 
the polymeric matrix.  Ibuprofen, an anti-inflammatory drug, was used as model to evaluate the 
utility of the PEA porous matrix as DDS. The drug release could be extended over a period of 83 
days. An initial burst release was observed only when the drug was loaded by the immersion 
technique (i.e., immersion of the matrix in a solution containing the drug).  
Poly(ethylene oxide) (PEO) has been grafted onto a PEA bearing amino pendant groups, forming a 
PEA-g-PEO graft copolymer [60]. The copolymer showed the ability to self-assemble into micelles 
in aqueous medium (Figure 4).  
<Insert Figure 4> 
The size of the micelles was tuned by varying the PEO content of the polymers and the method of 
micelle preparation. Under optimized conditions, the micelles could reach a diameter of 100 nm or 
less. The micelles showed the ability of encapsulating the hydrophobic model drug Nile Red and 
Page 21 of 50
Ac
ce
pte
d M
an
us
cri
pt
21 
 
releasing it over a period over 15 hours, in a pH-dependent manner. The cytoxicity tests performed 
in vitro on HeLa cells demonstrate that the micelles were non-cytotoxic.  The overall results made 
the authors suggest that such micelles could be useful as DDS. 
During the last decades, many researchers pointed out PDPs as important polymers to be used as 
DDS, however few research works on this matter are reported in the literature before 2004. 
In 1990, Yoshida et al. [97] reported for the first time a DDS based on a PDP     (poly[(L-alanyl)n-
g-ethyl-L-glutamyl-L-lactyl] -poly[(Ala)n-Glu(OEt)-Lac]), using the luteinizing-hormone-releasing 
hormone agonist as the active compound. Since then, other DDS based on PDPs have been 
successfully prepared. 
Ouchi et al. [98] prepared microspheres based on PLGA for the controlled release of proteins using 
PDP-b-PLLA block copolymers as biodegradable surfactants. Bovine serum albumin and lysozyme 
were used as model proteins. The purpose of the study was to evaluate the effect of the PDP block 
copolymer in the entrapment efficiency of the protein and in its release profile. It was found that in 
the presence of the ionic PDP-b-PLLA, the proteins had a sustained release for more than two 
months without an initial burst release. This result was attributed to the electrostatic interactions 
between the protein and the ionic block copolymer. The authors also found that during the 
formation of the microspheres and during release none of the proteins suffered denaturation. 
In research on DDS for cancer treatment,  Xie et al.  [99]  prepared the amphiphilic polymer 
poly((lactic acid)-co-[(glycolic acid)-alt-(l-glutamic acid)])-block-poly(ethylene glycol)-block-
poly((lactic acid)-co-[(glycolic acid)-alt-(l-glutamic acid)]) (P(LGG)-PEG-P(LGG)) to be used in 
the controlled release of paclitaxel. The amphiphilic polymer had carboxyl pendant groups used to 
covalently attach paclitaxel. The authors found that the polymer drug-conjugate self-assembled into 
micelles in aqueous medium with a unimodal distribution and a mean size of 119 nm. In vitro 
release tests showed that the paclitaxel release is pH dependent, being faster for lower pH (4-5).  
The in vitro antitumor activity of the conjugate against RBG-6 cells was evaluated by 3-(4,5-
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dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. The results showed that 
paclitaxel can be released from the conjugate without losing cytotoxicity. The overall results 
showed that the prepared conjugate can be used as a new formulation for the release of paclitaxel in 
cancer treatment. In another interesting approach, Zhao et al. [100] developed a DDS for paclitaxel 
using a triblock copolymer comprising PEG, PLLA and a PDP derived from L-alanine and GA. 
The triblock copolymer self-assembled in aqueous medium into micelles with a diameter of ca. 100 
nm that were used to encapsulate paclitaxel (Figure 5). The novel DDS enhanced the paclitaxel 
anti-cancer activity on two tumoral cellular lines (human lung adenocarcinoma cell, A-549, and 
colorectal carcinoma cell, HCT-116), prolonged its retention time in blood stream, which in turn 
improved its targeted disposition in vivo. It should be pointed out that the micelles formed from the 
triblock copolymer showed better performance than those formed from PEG and PLLA.  
<Insert Figure 5> 
 
3.2 Gene Delivery 
Gene therapy can be defined as the transfer of genetic material, a functional gene or 
deoxyribonucleic acid (DNA)/ribonucleic acid (RNA) fragment, into specific cells to prevent or 
treat a disease [101]. The success of gene therapy is largely dependent on the development of safe 
and efficient gene delivery systems (GDSs).  Ideally, a GDS should 1) display high specificity for 
the targeted cell, 2) protect the genetic material from undesirable interactions and degradation, and 
3) enhance cell binding and intracellular delivery into cytoplasm or into nucleus [102].  In the last 
two decades, many efforts have been made towards the development of new biodegradable 
polymers to be used in GDS.  
Yamanouchi et al. [103] prepared cationic L-arginine based PEAs that were used to bind plasmid 
DNA (pDNA).  The PEAs showed high binding capacity toward pDNA and showed an ability to 
transfect rat vascular smooth muscle cells that was comparable to Superfect®, a commercial 
transfection reagent. However, unlike Superfect®, the PEAs induced low toxicity over a wide range 
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of dosages. Temperature active endocytosis was found to be the mechanism of pDNA delivery to 
the cells. The results showed that a large portion of DNA was trapped in acidic endocytotic 
compartments, and was not expressed, a the main drawback presented by this GDS requiring 
further studies. 
The PDP poly(D,L-lactide-co-hydroxy-L-proline) (PLHP) developed by Li and Huang [104] as 
carrier for pDNA exhibited less toxicity for human embryonic kidney 293 cell line than 
poly(ethyleneimine) (PEI) and poly(L-lysine hydrochloride) (PLys). The release of pDNA from 
PLHP microspheres showed an initial burst release followed by a slower and sustained release over 
a period of 18 days. The pDNA/PLHP complexes demonstrated higher transfection efficiency for 
periods up to one week than PEI and PLys. The overall results demonstrated that the biocompatible 
and biodegradable PLHP is a promising candidate for long-term gene delivery. 
Park and Healy [105] prepared the triblock copolymer poly (L-lysine-g-(lactide-b-ethylene glycol)) 
and investigated its use as DNA. It was found that the triblock copolymers were able to condense 
DNA at lower amine-to-phosphate ratio when compared to PLys and showed the capacity of 
protecting the genetic material from intracellular nucleases. The decrease in the amount of PLys 
necessary for complete DNA condensation may improve transfection efficiency and reduce overall 
cytotoxicity. 
Li et al. [106] reported the preparation of an amphiphilic polycationic dendritic poly(L-lysine)-b-
poly(L-lactide)-b-dendritic poly(L-lysine) with two second-generation PLys dendrons and a central 
hydrophobic biodegradable poly(L-lactide) block to be used as a pDNA carrier (Figure 6). The 
amphiphilic polycationic macromolecule showed very low toxicity to human hepatocellular 
carcinoma cell line (SMMC-7721) when compared to PLys (23,000 Da) and PEI (2,000 Da). In 
addition, it was effective in binding pDNA and the in vitro gene transfection experiments indicated 
a transfection efficiency 10 times higher than that of naked DNA.  
<Insert Figure 6> 
Page 24 of 50
Ac
ce
pte
d M
an
us
cri
pt
24 
 
 
 
3.3 Tissue Engineering 
Tissue engineering is an interdisciplinary field that combines life sciences, materials science and 
engineering, which aims at the regeneration of tissues and restoration of organ functions through 
implantation of cells/ tissues grown outside the body or by stimulating cells to grow into an 
implanted matrix. The key elements of tissue engineering are cells, three-dimensional scaffolds and 
growth factors. For tissue engineering is desirable to have a biodegradable material that will 
disappear as the regeneration process takes place. Polymers for tissue engineering should be 
selected in terms of cytotoxicity, ability to support cell growth, inflammatory properties, and 
mechanical properties. PEAs based on α-amino acids and/ or α-hydroxy acids are viable candidates 
for such purpose [18, 21].   
PEAs based on L-leucine, L-lysine, fatty diacids and diols were used to attach 4-amino-TEMPO 
[36], and.the polymers were used as stents coatings [107]. The PEAs based coatings were able to 
support a natural healing response by attenuating the pro-inflammatory response to the implant and 
promoting growth of appropriate cells for tissue repair. In addition, the endothelial cells were able 
to adhere and proliferate on these copolymers [107] 
Knight et al. [47] prepared a set of α-amino acids based PEAs by solution and interfacial 
polycondensation and their applicability in vascular tissue engineering was investigated.  The 
authors found that the PEAs were able to support HCASMCs attachment, spreading and 
proliferation, which make them good candidates for vascular tissue engineering scaffolds. 
Recently, Knight et al. [108] prepared films from PEAs based on the α-amino acids L-lysine and 
L-phenylalanine  and evaluated the formation of focal adhesions of HCASMCs to the PEAs films 
surfaces by the waveguide evanescent field fluorescence microscopy technique. The results 
indicated that the PEAs under study can promote integrin signaling, which is crucial for cell 
survival, migration and proliferation. This feature is very attractive for scaffold-guided vascular 
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tissue engineering. Also in the field of vascular tissue engineering, Karimi et al. [59] prepared 
PEAs containing α-amino acids (L-phenylalanine, L-methionine), diols (1,4-butanediol, 1,6-
hexanediol) and sebacic acid by interfacial polymerization.  HCASMs were cultured onto PEA 
films for 48 h and the results showed a well spread morphology. The 3-D scaffolds obtained from 
the PEAs have shown adequate morphology and porosity to be used in tissue engineering 
applications. 
Regarding the application of PDPs in tissue engineering applications, the most representative work 
is from Ohya research group [109].  The authors prepared 3-D porous sponges by the freeze-drying 
technique based on poly(depsipeptide-co-lactide) copolymers, using depsipeptides based on L-
lysine and L-aspartic acid. The authors investigated the ability of the sponges to promote cell 
adhesion and growth and found that the sponges were suitable for such purpose. In addition, it was 
found that the sponges were biodegradable, with a biodegradation rate dependent on the amount of 
depsipeptide in the copolymer. 
 
4 Conclusions and Outlook 
 
PEAs based on α-amino acids and/or α-hydroxy acids constitute an attractive family of polymers 
due to their intrinsic properties.  Besides gathering in the same entity the best properties of 
polyesters and polyamides, the presence of the α-amino acid contributes to increase the overall 
biodegradability and biocompatibility of the PEAs. In addition, if a α-amino acid with a functional 
side chain is used, there is the possibility of further modifications, increasing the range of 
applications. The great number of investigations reported in the literature exploring the use of 
PEAs in different biomedical areas (e.g., DDS, GDS, tissue engineering) are a clear indication of 
the potential of this family of polymers. In fact, α-amino acids based PEAs have already been 
tested as drug-eluting stent coatings in NOBLESS clinical trials, and the results indicated that the 
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PEA coated stent was safe in humans. This fact constitutes a notable leap forward for α-amino 
acids based PEAs to move from the bench scale to real clinical applications. 
Along the years different PEAs have been synthesized either by the ROP of depsipeptides or by the 
polycondensation of α-amino acids with α-hydroxy acids or dicarboxylic acids and diols. Both 
methods have advantages and disadvantages, meaning that there is still a space for researchers to 
continue exploring alternative methods for the synthesis of α-amino acids and/or α-hydroxy acids 
based PEAs. The work from our research group [94, 95] indicates that interfacial polymerization is 
a very promising method to synthesize such PEAs. Nevertheless, some optimization is needed to 
obtain polymers with an adequate molecular weight for processing to useful products.  
To sum up, PEAs based on α-amino acids and/or α-hydroxy acids can be seen as an interesting 
promise for biomedical applications, but to settle definitely their position in the biomedical field, 
many more tests at the clinical level are needed.  Also, it would be beneficial to continue on 
exploring the development of PEAs bearing pendant reactive groups for further functionalization, 
to widen the range of applications of this family of polymers. 
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Fig. 1. Structure of the most used poly(α-hydroxy acids). 
 
Fig. 2. Structures of poly(L-glutamic acid) (A) and poly(aspartic acid) (B). 
 
Fig. 3. Leaving groups (A) and condensing agents (B). 
 
Fig. 4. Structure of the amphiphilic PEA-g-PEO graft copolymer (A) and self-assembly of the 
amphiphilic graft copolymer in aqueous medium (B). 
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Fig. 5. Structure of the amphiphilic PEG-PLLA-PDP copolymer (A) and self-assembly of the 
amphiphilic  copolymer in aqueous medium (B). 
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Fig. 6. Amphiphilic polycationic dendritic poly(L-lysine)-b-poly(L-lactide)-b-dendritic poly(L-
lysine) with two two-generation PLys dendrons and a central hydrophobic biodegradable 
poly(L-lactide). 
 
 
Scheme Captions 
Scheme 1. Synthesis of PEAs containing a-amino acids from a thermal polycondensation of a diol 
and a diamide-diester. R and R2: alkyl chain of variable length; R1: α-amino acid side 
chain. 
 
Scheme 2. Representation of the ‘leaving group’ method. 
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Scheme 3. Solution polycondensation method for the preparation of α-amino acid based PEAs. 
 
Scheme 4. Interfacial polycondensation method for the preparation of α-amino acid based PEAs. 
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Scheme 5. ROP of morpholine-2,5-dione derivatives.  
 
Scheme 6. Copolymerization reaction of depsipetides with (A) glycolide, (B) lactide, and  (C)  ε-
CL. 
 
Scheme 7. Melt polycondensation reaction for obtaining of polydepsipeptides. 
 
Scheme 8. Preparation of polydepsipeptides by solution polycondensation 
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Table 1 PEAs prepared by solution polycondensation (Tg-glass transition temperature, ºC; Tm-melting 
temperature, ºC; Mn-number average molecular weight, g.mol
-1; GPC-gel permeation 
chromatography; PS-polystyrene) 
Diol Dicarboxylic Acid 
α-amino acid 
or 
α-amino acid derivative 
Reaction 
Conditions 
PEAs’ main features 
1,3-propanediol 
1,4-butanediol 
1,6-hexanediol 
Adipic acid 
Sebacic acid 
L-valine 
L-leucine 
L-isoleucine 
DL-norleucine 
L-and DL-
phenylalanine 
Methionine 
DMA, Et3N, 
65 ºC, 48 h, N2  
24000< Mn, GPC(PS standards) < 107 000
11 < Tg < 58  
101< Tm <111  
PEAs soluble in CHCl3 
PEAs with highly hydrophobic 
groups effectively degraded by
chymotrypsin (α-CT) 
1,4:3,6-
dianhydrosorbitol 
1,4:3,6-
dianhydromannitol 
Adipic acid 
Suberic acid 
Sebacic acid 
Dodecanedioic acid 
L-phenylalanine 
L-leucine 
L-isoleucine 
L-methionine 
DMA, Et3N, 
65 ºC, 48 h, N2 
6000< Mn, GPC(PS standards) < 32000
 
60 < Tg < 120 
PEAs effectively degraded by α-CT
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1,4:3,6-dianhydro-D-
glucitol 
Adipic acid, 
Pimelic acid, 
Suberic acid, 
Azelaic acid, 
Sebacic acid, 
Dodecanedioic acid 
Alanine 
Glycine 
Glycylglycine 
NMP, Et3N,40 
ºC, 96 h, N2  
10000< Mn,GPC(poly(8-oxa-6-azobicyclo[3.2.1]octan
38000 
45< Tg < 66 
PEAs derived from sebacic acid, gl
glycylglycine are semi-crystalline (
164, respectively) 
PEAs soluble in dimethylsulfoxide 
DMF. 
1,4-butanediol 
1,6-hexanediol 
2- butene-1,4-diol 
Adipic acid, 
Sebacic acid 
Fumaric acid 
L-phenylalanine 
DMA, Et3N,60 
ºC/70 ºC, 24-
96 h,N2  
10000< Mn, GPC (PS standard) < 30000 
46 < Tg < 61 
216 < Tm < 250  
PEAs soluble in DMSO and DMF.
1,4-butanediol 
Succinic acid 
Adipic acid 
Sebacic acid 
Fumaric acid 
L-phenyalanine 
DMA,Et3N, 
60/70ºC, 48h 
N2 
15000<Mn, GPC (PEA standard)<60000 
40<Tg<103 
103<Tm<250 
PEAs soluble in DMSO and DMF
PEAs effectively degraded by α-CT
1,6-hexanediol 
1,8-octanediol 
Adipic acid 
Sebacic acid 
Dodecanoic acid 
L-leucine 
L-phenylalanine 
L-lysine 
DMA, Et3N, 
80ºC, 16h, N2 
22000<Mn, GPC (PS standard)<40000 
6.7<Tg<32.8 
103<Tm<250 
PEAs effectively degraded by α-CT
Diethylene glycol 
Triethyleneglycol 
Tetraethyleneglycol 
Adipic acid 
Sebacic acid, 
Fumaric acid 
L-phenylalanine 
DMA, Et3N,60 
ºC/70 ºC, 48 
h,N2  
2600 < Mn, GPC (PS standard) <27300 
12<Tg <82  
58 <Tm< 233 
PEAs soluble in DMSO, DMF and 
PEAs degraded by α-CT through a 
mechanism 
1,4-butanediol Succinic acid 
L-phenylalanine 
ε-protected-L-lysine 
DMA, Et3N, 
70ºC, 48h 
26900< Mn, GPC (PS standard)<56600 
51<Tg <57  
The deprotection procedures did no
degradation of the polymer backbon
The amine pendant functional grou
functionalized with different moieti
The inclusion of L-lysine in the pol
backbone improved significantly bo
and enzymatic degradation 
1,4-butanediol 
1,8-octanediol 
Succinic acid 
Terephthalic acid 
L-alanine 
L-phenylalanine 
L-lysine  
L-aspartic acid 
DMA, Et3N, 
70ºC, 48h 
18200 < Mn, GPC (PS standard) <56600  
The incorporation of L-lysine and L
in the polymer backbone lead to a d
Tg  and crystalinities 
The deprotection procedure did not
degradation of the polymer backbon
The deprotected polymers were abl
modified with different moieties. 
1,6-hexanediol Sebacic acid 
L-phenylalanine 
L-lysine 
DMA, Et3N,80 
ºC, 24 h, N2  
18400 < Mn, GPC (PS standard) <104000 
20 <Tg <33  
58 <Tm< 233 
PEAs presented an amorphous natu
PEAs soluble in DMSO and DMF
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PEAs supported bovine aortic cell p
without cytotoxicity 
1,2-ethylenediol 
1,4-butanediol 
1,6-hexanediol 
Succinic acid 
Sebacic acid 
DL-2-allylglycine 
L-phenylalanine 
DMA or 
DMSO, 
Et3N,70 ºC, 48 
h,N2  
33000< Mn, GPC (PS standards) <50000  
20 <Tg <38 
PEAs highly soluble in DMSO and
partially soluble in  THF and CHCl
1,4-butanediol 
1,6-hexanediol 
diethylene glycol 
tetraethylene glycol 
Succinic acid 
Sebacic acid 
DL-2-allylglycine 
L-Arginine 
 
DMA, Et3N,70 
ºC, 48 h, N2  
20000< Mn, GPC (PS standards) <33500  
18 ºC <Tg <33 ºC 
PEAs highly soluble in H2O, DMSO
methanol. 
PEAs did not elicit any adverse effe
aortic cells. 
1,4-butanediol Sebacic acid 
L-valine 
Serine 
DMA, Et3N,80 
ºC, 24 h, N2  
27000 < Mn, GPC (PS standards) <46000 
27 <Tg <31 
PEAs presented an amorphous natu
PEAs soluble in DMSO, THF and C
PEAs did not elicit any kind of adv
human fibroblasts cells. 
1,4-butanediol 
1,8-octanediol 
Sebacic acid 
L-alanine 
L-phenylalanine 
L-lysine 
DMA, Et3N,70 
ºC, 48 h, N2  
19000 < Mn, GPC (PS standards) <53000 
13 <Tg <40  
PEAs supported the attachment of h
coronary artery smooth muscle cell
(HCASMCs). 
1,2-ethanediol 
1,3-propanediol 
1,4-butanediol 
Succinic acid 
Adipic acid 
Sebacic acid 
Fumaric acid 
L-arginine 
L-arginine hydrochloride 
DMA, Et3N,70 
ºC, 48 h, N2  
24600 < Mn, GPC (PS standards)  <130800
30 <Tg <125 
PEAs presented an amorphous natu
PEAs soluble in DMSO, DMA, DM
and H2O. 
PEAs did not exert any toxic effect
smooth muscle cells. 
Poly(ε-caprolactone) 
diol 
Adipic acid 
Sebacic acid 
Fumaric acid 
L-phenylalanine 
DMA, Et3N,70 
ºC, 48 h, N2  
4200 < Mn, GPC (PS standards) <16400  
43 <Tm <77  
PEAs soluble in formic acid, DMSO
trifluoroethanol 
1,2-ethanediol 
1,3-propanediol 
1,4-butanediol 
1,6-hexanediol 
Fumaric acid L-arginine 
DMA, Et3N,70 
ºC, 48 h, N2  
12900 < Mn, GPC (PS standards) <15700 
88 <Tg <112  
PEAs soluble in DMSO, DMF and 
 
 
 
Table 2. PEAs synthesized by interfacial polycondensation (Tg-glass transition temperature, ºC; Tm-melting 
temperature, ºC; Mn-number average molecular weight, g mol
-1,  [η]-intrinsic viscosity, dL g-1; 
GPC-gel permeation chromatography; PS-polystyrene) 
Diol Diacyl chlorides α-Amino acid  Reaction Conditions PEAs’ main features 
1,6-hexanediol Succinyl chloride Glycine CH2Cl2/H2O 0.23<[η]<0.40 (Dichloroacetic acid, 25 ºC) 
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Glutaryl chloride 
Adipoyl chloride 
Pimeloyl Chloride 
Suberyl Chloride 
Azeloyl Chloride 
Sebacoyl chloride 
Na2CO3 
RoomT 
3400 < Mn, GPC (PS standards)< 8100  
-7.3 <Tg< 10  
PEAs with multiple fusion peaks (134<Tm<160) 
PEAs were effectively biodegraded by papain. 
1,6-hexanediol Sebacoyl Chloride L-or D-alanine 
CCl4/H2O 
Na2CO3 
RoomT 
3800 < Mn, GPC (PS standards)< 11100 
-5<Tg< 1 
87<Tm< 95 
PEAs were biodegraded by enzymes through the 
hydrolysis of ester linkages. 
1,12-
dodecanodiol 
Sebacoyl Chloride L-alanine 
CCl4/H2O+Acetone 
Na2CO3 
RoomT 
 [η]=0.60 (Dichloroacetic acid, 25 ºC) 
Mn, GPC (PS standards)=9000  
Tg=0.7  
Tm,1=100; Tm,2=122  
PEA is hydrolytically degradable. 
PEA is effectively degraded by papain, through a 
surface eroding mechanism. 
PEA was found weaklycytotoxic to L929 mouse 
fibroblasts cells. 
1,6-hexanediol 
1,12-
dodecanodiol 
Succinyl chloride 
Glutaryl chloride 
Adipoyl chloride 
Pimeloyl Chloride 
Suberyl Chloride 
Azeloyl Chloride 
Sebacoyl chloride 
Dodecanoyl chloride 
Glycine 
L-or DL-alanine 
L-valine 
CCl4/H2O 
Na2CO3 
RoomT 
0.20 <[η]< 1.00 (Dichloroacetic acid, 25 ºC) 
-7.3 <Tg< 0.7  
75 <Tm< 152 
PEAs were soluble in formic acid, DMSO, DMF, 
NMP 
PEAs degraded slowly under simulated 
physiological conditions. 
PEAs were degradaded by enzymes through a bulk 
eroding mechanism. 
1,6-hexanediol Sebacoyl chloride 
Glycine 
L-alanine 
CCl4/H2O 
Na2CO3 
RoomT 
0.45 <[η]< 1.05 (Dichloroacetic acid, 25 ºC) 
PEAs with multiple fusion peaks (126<Tm< 194) 
PEAs derived from L-alanine are less crystalline 
than their glycine counterparts 
PEAs degrade slowly under simulated physiological 
conditions 
PEAs are biodegraded by both proteinase K and 
papain 
1,4-butanediol 
1,6-hexanediol 
Sebacoyl chloride Glycine 
CH2Cl2/H2O 
Na2CO3 
RoomT 
0.25 <[η]< 0.42 (Dichloroacetic acid, 25 ºC) 
122<Tm< 130 
PEAs are effectively degraded by papain 
PEAs showed to be non-cytotoxic for human 
dermal fibroblasts 
1,4-butanediol 
1,6-hexanediol 
Sebacoyl chloride 
L-phenylalanine 
L-methionine 
CH2Cl2/H2O 
Na2CO3 
RoomT 
28000<Mn, GPC (PS standards)< 45000 
-2 <Tg< 39  
PEAs showed an amorphous nature 
PEAs were biodegraded by α-CT 
PEAs supported the proliferation of HCASMCs 
without cytotoxicity 
1,4-butanediol Sebacoyl chloride L-alanine CH2Cl2/H2O 17000 < Mn, GPC (PS standards)< 73400  
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1,6-octanediol L-phenylalanine 
L-lysine 
Na2CO3 
RoomT 
12<Tg< 44  
PEAs supported the attachment of HCASMCs. 
 
 
Table 3. Overview of the different PDPs prepared along the years (Tg-glass transition temperature, ºC; Tm-
melting temperature, ºC; Mn-number average molecular weight, g mol
-1,  Mw-weight average 
molecular weight, g mol-1; LALLS-low angle laser light scattering; GPC-gel permeation 
chromatography; PS-polystyrene; PMMA-poly(methyl methacrylate)) 
 
α-Amino acid α-Hydroxy Acid Cyclic 
comonomer 
Reaction Conditions PDPs’ main features Reference 
Non-Functionalized HomoPDPs 
Glycine DL-LA x 
130 ºC 
0.7-1 mbar 
28-90 h 
 Sn(Oct)2 
16000 <Mw, LALLS (633nm)< 23000 
 
[63] 
Glycine 
Valine 
Alanine 
GA 
DL-LA 
x 
100-165 ºC 
0.08 mbar 
48 h 
Sn(Oct)2 
9000 <Mw, LALLS (633 nm)< 74000 
93 <Tg< 117  
PDPs were amorphous, except that derived 
from glycolic acid and alanine (Tm=221) 
 
[73] 
Valine 
GA 
LA 
x 
142 ºC  
Sn(Oct)2 
Tin acetylacetonate 
29500< Mn, GPC (PS standards)< 44500 
 
[74] 
Valine GA x 
100ºC/ 130ºC  
72/168 h 
Porcine Pancreatic Lipase 
Lipase derived from 
Pseudomonas species 
4500 < Mn, GPC (PS standards)< 17500  
PDP showed an amorphous nature. 
 
[75] 
Valine 
Leucine 
Isoleucine 
GA 
LA 
x 
120º C  
72/144 h 
Porcine Pancreatic Lipase 
6900 < Mn, GPC (PS standards)< 15200 [76] 
Functionalized HomoPDPs 
L-aspartic acid 
L-glutamic acid 
L-lysine 
GA x 
115 ºC , 0.5-14 days 
(poly (glycolic acid-alt-Lys(Z)) 
(A) 
155 ºC, 3-6h 
(poly(glycolic acid-alt-
Asp(OBzl)) (B) 
160  ºC, 15-20h 
(poly(glycolic acid-alt-
Glu(OBzl))(C) 
Sn(Oct)2 
1200<MnA, GPC (PS standards)< 4300 
2000 <MnB, GPC (PS standards)< 3000  
MnC, GPC (PS standards)=2200  
After deprotection, the PDPs were soluble 
in water. 
PDPs were degraded by both proteases and 
estereases. 
[77, 78] 
L-aspartic acid GA x 152 ºC 5800 <Mn, GPC (PS standards)< 12800 [79] 
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20-290 min  
Sn(Oct)2 
After deprotection, the PDP is water-
soluble. 
 
L-serine GA x 
165 ºC / 3 min 
150 ºC / 48 h  
Sn(Oct)2 
Mn, GPC (PS standards) = 4000  [68] 
L-cysteine GA x 
125 ºC 
2-10 days  
Sn(Oct)2 
895 <Mn, GPC (PS standards)< 1400  [67] 
D,L-allylglycine 
L-lysine 
GA x 
110 ºC, 5-168 h 
(poly(Glc-alt-(Z)-L-Lys)) (A) 
110 ºC, 20 h 
(poly(Glc-alt-(Boc)-L-Lys)) 
(B) 
(poly(Glc-alt-L-allylglycine)) 
(C) 
Sn(Oct)2 
1000 <MnA, GPC (PMMA standards)< 24400 
MnB, GPC (PMMA standards)= 21700  
MnC, GPC (PMMA standards)= 13300 g.mol-1 
 
 
[80] 
Non- Functionalized CoPDPs 
Glycine DL-LA D,L-lactide 
135 ºC 
33h  
Sn(Oct)2 
6000<Mn, LALLS (633 nm)< 15400  
 (Mn increased with the increase of the 
amount of D,L-lactide  in the feed) 
55 <Tg< 109  
 
 
[65] 
Glycine 
Alanine 
Valine 
 
 
GA 
LA 
ε-CL 110 ºC  
Sn(Oct)2 
10000<Mw, LALLS (633 nm)< 83000 
Tg< 0 ºC 
[81] 
Functionalized CoPDPs 
L-lysine 
L-aspartic acid 
L-cysteine 
LA 
ε-CL 
D,L-lactide 
130 ºC 
48 h 
Sn(Oct)2 
Before deprotection 
7600 <Mn, ε-CL, GPC (PS standards)< 24000  
5400 <Mn, D,L-LA, GPC (PS standards)< 31000  
After deprotection 
4400 <Mn, ε-CL, GPC (PS standards)< 20000  
-43 <Tg, ε-CL< -21  
41 <Tm, ε-CL< 67  
6200 <Mn, D,L-LA, GPC (PS standards)< 21000  
43 <Tg, D,L-LA < 52  
The coPDP with D,L-lactide were 
amorphous.  
[66] 
L-lysine L-LA L-lactide 
100 ºC 
24 h  
Sn(Oct)2 
Mn, GPC (PS standards)= 40000  
The coPDP was amorphous and was 
soluble in CH2Cl2 and CHCl3 
[82] 
L-serine GA 
ε-caprolactone 
D,L-lactide 
165 ºC, 3 min 
130 ºC, 48 h  
Sn(Oct)2 
8300 <Mn, ε-CL, GPC (PS standards)< 11400  
-50 <Tg, ε-CL< -46  
52 ºC<Tm, ε-CL< 54  
[68] 
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4000 <Mn, D,L-LA, GPC (PS standards)< 36000  
51 <Tg, D,L-LA < 60  
147 <Tm, D,L-LA < 177.5  
Tm decreased as the content of serine in the 
coPDP increased 
L-lysine 
L-aspartic acid 
GA L-lactide 
115 ºC, 48 h  
(poly(LA-[Glc-(Z)-Lys])) (A) 
160 ºC, 48 h 
(poly(LA-[Glc-(OBzl)-Asp])) 
(B) 
Sn(Oct)2 
3000 <Mn, A, GPC (PS standards)< 10200 
4300 <Mn, B, GPC (PS standards)< 14100  
32 <Tg, A,dep < 43  
140 <Tm, A,dep < 148  
35 <Tg, B,dep < 45  
129 <Tm, B,dep < 155  
[69] 
L-cysteine GA L-lactide 
125 ºC 
48 h 
Sn(Oct)2 
Before deprotection 
1500 <Mn, GPC (PS standards)< 6500 
After deprotection 
4500 <Mn, GPC (PS standards)< 6500  
34 <Tg< 45  
130 <Tm< 148 
[67] 
L-serine L-LA L-lactide 
110 ºC 
24 h 
Sn(Oct)2 
Before deprotection 
Mn, GPC (PS standards) =24000 /47000  
Tg= 60  
Tm=165/ 167  
After deprotection 
Mn, GPC (PS standards) =31000 /49000  
Tg= 60 /63  
Tm=157/ 168 
[83] 
L-aspartic acid GA ε-CL 
152 ºC 
60-250 min  
Sn(Oct)2 
Before deprotection 
5800 <Mn, GPC (PS standards)< 43000  
[71] 
L-serine GA L-lactide 
170 ºC, 2 min 
135 ºC, 48 h 
Sn(Oct)2 
Before deprotection 
18800 <Mn, GPC (PS standards)< 24900  
After deprotection 
11100 <Mn, GPC (PS standards) < 19800  
42.5 <Tg< 60  
138 <Tm< 152  
[84] 
L-serine GA ε-CL 
130 ºC 
48 h 
Sn(Oct)2 
Before deprotection 
21000 <Mn, GPC (PS standards)< 37300  
 
[70] 
L-lysine 
L-aspartic acid 
GA L-lactide 
115 ºC, 48 h  
(poly(LA-[Glc-(Z)-Lys])) (A) 
160 ºC, 2min  
135 ºC, 48 h 
(poly(LA-[Glc-(OBzl)-Asp])) 
(B) 
Sn(Oct)2 
After deprotection 
MnA, GPC (PS standards)=18000 /22000  
MnB, GPC (PS standards)=63000 /87000  
The films prepared from the PDP showed 
high fibroblastos cells attachment ability. 
 
[72] 
 
 
Table 4. Monomers used in the preparation of polydepsipeptides by direct polycondensation (Tg-glass 
transition temperature, ºC; Tm-melting temperature, ºC; Td-degradation temperature, ºC; Mn-number 
Page 49 of 50
Ac
ce
pte
d M
an
us
cri
pt
49 
 
average molecular weight, g mol-1; Mv-viscosity average molecular weight, g mol
-1; GPG-gel 
permeation chromatography; PS-polystyrene) 
mino acid α-hydroxy acid Reaction Conditions PDPs’ main features Referenc
utamic acid 
GA 
DL-LA 
180 ºC  
10 h 
No catalyst 
5900<Mn, GPC (PS standards)<9200 
52 <Tg<62  
231.3<Td< 258.2  
[87] 
ine DL-LA 
140 ºC  
8 h 
SnO 
1400<Mn, GPC (PS standards)<4000 
47 <Tg<66  
12 <Tm< 36  
(Copolymers with glycine molar contents higher than 20 were 
amorphous) 
[88] 
ine 
nine 
enylalanine 
DL-LA 
GA 
180 ºC, 10 h 
Zn, Al, SnCl2.2H2O 
1600<Mv<9800 
Tg, Poly(LA-GA-Gly)=68.32  
Tg, Poly(LA-GA-Phe)=51.17  
Tg, Poly(LA-GA-Ala)=30.87  
[85] 
partic acid L-LA 
140 ºC 
(pre-polymerization of L-LA and  
L-aspartic acid) 
140 ºC-180 ºC 
(melt polycondensation) 
SnCl2, SnO, ZnCl2 
ZnO, pTSA 
3000<Mn, GPC (PS standards)<6100 a) 
50 <Tg<80 a) 
95 <Tm< 134 a) 
(Copolymers with L-LA molar contents lower than 20 were 
amorphous) 
 
[90] 
 
The values correspond to the copolymers obtained from the bulk polymerization of L‐aspartic acid and L‐
lactic acid, at 160 ºC, for 10 h, using SnCl2 as catalyst. 
 
Table 5. Main advantages and disadvantages of the synthesis methods used in the preparation of PEAs 
based on α‐amino acid and/or α‐hydroxy acids. 
Synthesis Method Advantages Disadvantages 
Solution Polycondensation 
Mild reaction conditions 
High polymerization rates 
Minimal side reactions 
Monomers with high purity are required 
Overall bulk stoichiometry needed 
Extensive purificationof the polymer is 
required 
Interfacial polycondensation 
Mild reaction conditions 
Bulk stoichiometry is not needed 
Short polymerization times 
Possiblity of hydrolysis of the diacyl 
chlorides 
ROP of depsipeptides Simple polymerization method 
Severe reaction conditions 
Use of metallic catalysts 
Low availability of methods for the 
synthesis of cyclic depsipeptides 
Low yields in the preparation of cyclic 
depsipeptides 
Ocurrence of undesirable side reactions 
Melt polycondensation of Simple polymerization method Severe reaction conditions 
Page 50 of 50
Ac
ce
pte
d M
an
us
cri
pt
50 
 
α-amino acids and α-hydroxy acids Use of metallic catalysts 
Ocurrence of racemization 
 
 
 
 
 
